Purdue's New Ch. 11 Plan Sidesteps Nonconsensual Releases

By Hilary Russ · February 24, 2025, 6:03 PM EST

Mediators helping to craft a new settlement in the case of bankrupt OxyContin maker Purdue Pharma LP said in their latest update in New York bankruptcy court that the company's revised...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Report

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Hilary

February 18, 2025
US Trustee Balks At Jones Day Fees In NY Diocese Ch. 11
February 18, 2025
Fight For Sub V Status Bedevils Hub City Home Health Biz
February 05, 2025
Wave Of Defaults Looms For Fed's Main Street Loans
January 28, 2025
Corsa Coal Sale Date, Use Of Morgan Stanley Account OK'd
January 27, 2025
Party City Inks Deal To Sell IP, Assets In 2nd Ch. 11
January 24, 2025
Mass Tort Atty Files Ch. 11 Owing $202M To Litigation Funders
January 21, 2025
Receiver Sought For Partnership That Funded Affleck Films
January 13, 2025
Purdue Pharma Inks Draft Deal, Seeks Mediation Extension
January 08, 2025
Corsa Coal Gets Green Light For Ch. 11 Financing, Wages
January 01, 2025
What Lower Rates? Ch. 11s Expected To Stay Sticky In 2025